Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $10.9B |
| FY2017, ended Dec 31, 2017 | $8.07B |
| FY2018, ended Dec 31, 2018 | $11.9B |
| FY2019, ended Dec 31, 2019 | $23.2B |
| FY2020, ended Dec 31, 2020 | $39.0B |
| FY2021, ended Dec 31, 2021 | $49.0B |
| FY2022, ended Dec 31, 2022 | $38.3B |
| FY2023, ended Dec 31, 2023 | $62.7B |
| FY2024, ended Dec 31, 2024 | $81.7B |
| FY2025, ended Dec 31, 2025 | $48.2B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $43.0B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.90B |
| FY2017, ended Dec 31, 2017 | $4.48B |
| FY2018, ended Dec 31, 2018 | $4.86B |
| FY2019, ended Dec 31, 2019 | $5.59B |
| FY2020, ended Dec 31, 2020 | $5.98B |
| FY2021, ended Dec 31, 2021 | $7.55B |
| FY2022, ended Dec 31, 2022 | $8.63B |
| FY2023, ended Dec 31, 2023 | $9.87B |
| FY2024, ended Dec 31, 2024 | $11.3B |
| FY2025, ended Dec 31, 2025 | $11.9B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $12.4B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $22.9M | $96.3M |
| FY2017, ended Dec 31, 2017 | $176M | $251M |
| FY2018, ended Dec 31, 2018 | $177M | $334M |
| FY2019, ended Dec 31, 2019 | $350M | $388M |
| FY2020, ended Dec 31, 2020 | $356M | $290M |
| FY2021, ended Dec 31, 2021 | $653M | $840M |
| FY2022, ended Dec 31, 2022 | $899M | $844M |
| FY2023, ended Dec 31, 2023 | $1.23B | $1.22B |
| FY2024, ended Dec 31, 2024 | $1.53B | $1.51B |
| FY2025, ended Dec 31, 2025 | $1.54B | $1.45B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.42B | $1.57B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $87.9M |
| FY2017, ended Dec 31, 2017 | $185M |
| FY2018, ended Dec 31, 2018 | $250M |
| FY2019, ended Dec 31, 2019 | $481M |
| FY2020, ended Dec 31, 2020 | $608M |
| FY2021, ended Dec 31, 2021 | $815M |
| FY2022, ended Dec 31, 2022 | $384M |
| FY2023, ended Dec 31, 2023 | $561M |
| FY2024, ended Dec 31, 2024 | $749M |
| FY2025, ended Dec 31, 2025 | $351M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $228M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | — |
| FY2017, ended Dec 31, 2017 | — |
| FY2018, ended Dec 31, 2018 | — |
| FY2019, ended Dec 31, 2019 | $0 |
| FY2020, ended Dec 31, 2020 | $0 |
| FY2021, ended Dec 31, 2021 | $0 |
| FY2022, ended Dec 31, 2022 | $0 |
| FY2023, ended Dec 31, 2023 | $0 |
| FY2024, ended Dec 31, 2024 | $0 |
| FY2025, ended Dec 31, 2025 | $0 |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 12.0% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.44B |
| FY2017, ended Dec 31, 2017 | 1.40B |
| FY2018, ended Dec 31, 2018 | 1.38B |
| FY2019, ended Dec 31, 2019 | 1.39B |
| FY2020, ended Dec 31, 2020 | 1.41B |
| FY2021, ended Dec 31, 2021 | 1.40B |
| FY2022, ended Dec 31, 2022 | 1.38B |
| FY2023, ended Dec 31, 2023 | 1.37B |
| FY2024, ended Dec 31, 2024 | 1.36B |
| FY2025, ended Dec 31, 2025 | 1.30B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.27B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $837M | $64.2M |
| FY2017, ended Dec 31, 2017 | $285M | $65.3M |
| FY2018, ended Dec 31, 2018 | $161M | $69.2M |
| FY2019, ended Dec 31, 2019 | $191M | $91.4M |
| FY2020, ended Dec 31, 2020 | $54.4M | $82.6M |
| FY2021, ended Dec 31, 2021 | $466M | $176M |
| FY2022, ended Dec 31, 2022 | $830M | $98.0M |
| FY2023, ended Dec 31, 2023 | $592M | $124M |
| FY2024, ended Dec 31, 2024 | $1.00B | $132M |
| FY2025, ended Dec 31, 2025 | $2.43B | $120M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.78B | $98.9M |
Valuation
At current price- Market Cap
- $35.4B
- P/E
- 24.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.8×
- Price / Book
- 16.1×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $12.4B
- Revenue Growth YoY
- 7.3%
- Revenue CAGR 3Y
- 11.4%
- Revenue CAGR 5Y
- 14.8%
- EPS Growth YoY
- −4.4%
- Net Income Growth YoY
- −7.9%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 14.7%
- Net Margin
- 11.4%
- FCF Margin
- 12.6%
- Return on Equity
- 49.6%
Earnings
Trailing 12 months- Net Income
- $1.42B
- EPS (diluted)
- $1.08
- EBITDA
- $2.20B
- Operating Income
- $1.82B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $228M
- Total Debt
- —. Short- and long-term borrowings, excluding leases
- Net Cash
- —. Cash − total debt
- Total Assets
- $8.86B
- Total Liabilities
- $6.66B
- Shareholders' Equity
- $2.20B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $2.33B
- Capital Expenditure
- $759M
- Free Cash Flow
- $1.57B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 0.96
Every ratio is calculated from the company’s reported figures.